e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Biology and molecular pathology of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CCR2, CCR5, their ligands and chemokine receptor-interacting protein FROUNT have impressive effects on pulmonary adenocarcinoma
M. Itakura, M. Shingyoji, T. Iizasa, Y. Yoshida, H. Ashinuma, Y. Miriya, H. Tamura (Chiba Prefecture, Japan)
Source:
Annual Congress 2013 –Biology and molecular pathology of lung cancer
Session:
Biology and molecular pathology of lung cancer
Session type:
Oral Presentation
Number:
4640
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Itakura, M. Shingyoji, T. Iizasa, Y. Yoshida, H. Ashinuma, Y. Miriya, H. Tamura (Chiba Prefecture, Japan). CCR2, CCR5, their ligands and chemokine receptor-interacting protein FROUNT have impressive effects on pulmonary adenocarcinoma. Eur Respir J 2013; 42: Suppl. 57, 4640
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
CD163 and CCR7 markers for macrophage polarisation in patients with lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Neurotrophin TrkB receptor mediates the epithelial to mesenchymal transition in lung adenocarcinoma cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Expression of interleukin-18 and interleukin-18 receptor mRNA in lung tissue samples from non small lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Macrophages promote urethane-induced lung adenocarcinoma
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
A role for cAMP-responsive element binding protein in lung adenocarcinoma
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
A requirement for IKKa in lung adenocarcinoma
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis
Source: Eur Respir J 2009; 34: 676
Year: 2009
Polymorphism of chemokine receptor gene CCR5 in patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 266s
Year: 2003
Inhibition of IRAK4 suppresses chemokine release from human bronchial epithelial cells
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
Surface vs. intracellular CTLA-4 expression in lung cancer
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Inhibition of human lung H460 cell proliferation by siRNA-mediated macrophage migration inhibitory factor (MIF) blocking
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept